SLC25A32 and adrenal cortex carcinoma: SLC25A32 was significantly associated with the pathological stage of adrenocortical carcinoma (ACC), KICH, KIRP, lung adenocarcinoma (LUAD), and uterine carcinosarcoma (USC) (Figure 1(d)).